ARID4B and gastric cancer: Folate-conjugated 3WJ-BRCAA1 siRNA-pRNA nanoparticles were successfully developed, and resulted in specific fluorescent targeted imaging, high efficient siRNA delivery, significantly inhibiting the growth of gastric cancer MGC803 cells, and reducing the size of gastric cancer xenografts in vivo, which exhibiting potential clinical applications.